Cite

HARVARD Citation

    Fessenden, T. et al. (2022). Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins. Journal for immunotherapy of cancer. 10 (7), p. . [Online]. 
  
Back to record